72.11.Z - Research and experimental development on biotechnology
46.5 - Wholesale of information and communication equipment
62.0 - Computer programming, consultancy and related activities
63 - Information service activities
72.19.Z - Other research and experimental development on natural sciences and engineering
77.4 - Leasing of intellectual property and similar products, except copyrighted works
86.90.A - Physiotherapeutical activities
86.90.E - Other human health activities notelsewhere classified
87.30.Z - Residential care activities for the elderly and disabled
96.09.Z - Other personal service activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,3 | -0,2 | -0,1 | 39,2 |
EBITDA | 0,4 | 0,4 | 0,5 | 19,8 |
Short time liabilities | 0,1 | 0 | 0 | -96,8 |
Equity capital | 0,4 | 0,2 | 0 | -92,7 |
Operating profit (EBIT) | -0,3 | -0,2 | -0,1 | 38,6 |
Assets | 1,5 | 0,7 | 0 | -98,3 |
Net profit (loss) | -0,3 | -0,2 | -0,1 | 39,2 |
Cash | 0,1 | 0 | 0 | 1972,7 |
Net income from sale | 0 | 0 | 0 | -100 |
Liabilities and provisions for liabilities | 1,1 | 0,5 | 0 | -100 |
Working assets | 0,2 | 0 | 0 | -69,4 |
Depreciation | 0,7 | 0,7 | 0,7 | -0,3 |
% | % | % | p.p. | |
Profitability of capital | -69,8 | -152,4 | -1266,6 | -1114,2 |
Equity capital to total assets | 25,5 | 22,2 | 98,4 | 76,2 |
Gross profit margin | -767,4 | -1732 | -964,6 | |
EBITDA Margin | 1208,1 | 3260,2 | 2052,1 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 706 | 152 | 2 147 483 648 | 2 147 483 496 |
Current financial liquidity indicator | 0.14475734531879425 | 0.028206391260027885 | 25.604520797729492 | 25,6 |
Net dept to EBITDA | -0.02462737448513508 | -0.00044028766569681466 | -0.0076162549667060375 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane